CA2325995A1 - Antagonistes de l'hormone liberant la gonadotropine (gnrh) - Google Patents
Antagonistes de l'hormone liberant la gonadotropine (gnrh) Download PDFInfo
- Publication number
- CA2325995A1 CA2325995A1 CA002325995A CA2325995A CA2325995A1 CA 2325995 A1 CA2325995 A1 CA 2325995A1 CA 002325995 A CA002325995 A CA 002325995A CA 2325995 A CA2325995 A CA 2325995A CA 2325995 A1 CA2325995 A1 CA 2325995A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- substituted
- aryl
- compound
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
L'invention porte sur des composés de la formule (I) et sur leurs sels pharmaceutiquement acceptables qui sont utilisés comme antagonistes de GnRH et, en conséquence, dans le traitement d'états relatifs à l'hormone sexuelle et à d'autres hormones chez l'homme et chez la femme.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8039998P | 1998-04-02 | 1998-04-02 | |
US60/080,399 | 1998-04-02 | ||
GBGB9811286.5A GB9811286D0 (en) | 1998-05-26 | 1998-05-26 | Antagonists of gonadotropin releasing hormone |
GB9811286.5 | 1998-05-26 | ||
PCT/US1999/006713 WO1999051231A1 (fr) | 1998-04-02 | 1999-03-29 | Antagonistes de l'hormone liberant la gonadotropine (gnrh) |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2325995A1 true CA2325995A1 (fr) | 1999-10-14 |
Family
ID=26313744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002325995A Abandoned CA2325995A1 (fr) | 1998-04-02 | 1999-03-29 | Antagonistes de l'hormone liberant la gonadotropine (gnrh) |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1067929A1 (fr) |
JP (1) | JP2002510628A (fr) |
AU (1) | AU3117899A (fr) |
CA (1) | CA2325995A1 (fr) |
WO (1) | WO1999051231A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1263759B1 (fr) | 1999-12-24 | 2010-09-08 | Aventis Pharma Limited | Azaindoles |
GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
SE0100566D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
SE0101692D0 (sv) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
GB0115109D0 (en) | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
GB0219472D0 (en) | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
US7253290B2 (en) | 2002-08-21 | 2007-08-07 | Astrazeneca Ab | Pyrazole derivatives as GnRH inhibitors |
ATE384066T1 (de) | 2002-08-21 | 2008-02-15 | Astrazeneca Ab | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren |
WO2005062795A2 (fr) | 2003-12-19 | 2005-07-14 | Plexxikon, Inc. | Composes et methodes de developpement de modulateurs de ret |
US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
DE102004033902A1 (de) | 2004-07-14 | 2006-02-16 | Zentaris Gmbh | Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's) |
WO2007059219A1 (fr) | 2005-11-15 | 2007-05-24 | Vertex Pharmaceuticals Incorporated | Azaindazoles utiles en tant qu'inhibiteurs de kinases |
WO2008063888A2 (fr) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Composés modulant l'activité de c-fms et/ou de c-kit et utilisations associées |
WO2009012283A1 (fr) | 2007-07-17 | 2009-01-22 | Plexxikon Inc. | Composés et procédés pour la modulation des kinases et leurs indications |
EP2095818A1 (fr) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Utilisation d'antagonistes LHRH dans des doses n'impliquant pas de castration |
SG173178A1 (en) | 2009-04-03 | 2011-09-29 | Hoffmann La Roche | Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
NZ629615A (en) | 2009-11-06 | 2016-01-29 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
EA028821B9 (ru) | 2011-02-07 | 2018-10-31 | Плексксикон, Инк. | Соединения и способы для модуляции киназ, а также показания к их применению |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2732969B1 (fr) * | 1995-04-14 | 1997-05-16 | Adir | Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU7333496A (en) * | 1995-10-19 | 1997-05-07 | Takeda Chemical Industries Ltd. | Quinoline derivatives as gnrh antagonists |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
1999
- 1999-03-29 AU AU31178/99A patent/AU3117899A/en not_active Abandoned
- 1999-03-29 WO PCT/US1999/006713 patent/WO1999051231A1/fr not_active Application Discontinuation
- 1999-03-29 CA CA002325995A patent/CA2325995A1/fr not_active Abandoned
- 1999-03-29 JP JP2000542002A patent/JP2002510628A/ja not_active Withdrawn
- 1999-03-29 EP EP99912919A patent/EP1067929A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU3117899A (en) | 1999-10-25 |
EP1067929A1 (fr) | 2001-01-17 |
JP2002510628A (ja) | 2002-04-09 |
WO1999051231A1 (fr) | 1999-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6025366A (en) | Antagonists of gonadotropin releasing hormone | |
CA2326185A1 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
CA2325995A1 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
CA2326143A1 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
US6288078B1 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
CA2326139A1 (fr) | Antagonistes de la gonadoliberine | |
CA2326140A1 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
CA2366615A1 (fr) | Composes 6-azaindole utilises comme antagonistes d'une hormone liberant la gonadotropine | |
CA2326184A1 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
US6077847A (en) | Antagonists of gonadotropin releasing hormone | |
US5985892A (en) | Antagonists of gonadotropin releasing hormone | |
US5998432A (en) | Antagonists of gonadotropin releasing hormone | |
US6180642B1 (en) | 6-azaindole compounds as antagonists of Gonadotropin releasing hormone | |
AU3868800A (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
CA2367126A1 (fr) | Composes de 6-azaindole comme antagonistes de la gonadoliberine | |
AU3868900A (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
US6110931A (en) | Antagonists of gonadotropin releasing hormone | |
US6228867B1 (en) | Antagonists of gonadotropin releasing hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |